Understanding the complexity of p53 in a new era of tumor suppression

Yanqing Liu(Cancer Genetics (United States)), Zhenyi Su(Cancer Genetics (United States)), Omid Tavana(Cancer Genetics (United States)), Wei Gu(Cancer Genetics (United States))
Cancer Cell
May 9, 2024
10.1016/j.ccell.2024.04.009
Cited by 421Open Access
Full Text

Abstract

Related Papers

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al.|Cell|1993|2.9k
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Sheau-Yann Shieh, Masako Ikeda, Yoichi Taya et al.|Cell|1997|2.1k
The first 30 years of p53: growing ever more complex
Arnold J. Levine, Moshe Oren|Nature reviews. Cancer|2009|2k
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
Roberto Montes de Oca Luna, Daniel S. Wagner, Guillermina Lozano|Nature|1995|1.4k
mdm2 expression is induced by wild type p53 activity.
Yaacov Barak, T. Juven, Rebecca Haffner et al.|The EMBO Journal|1993|1.3k